SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001367644-22-000061
Filing Date
2022-04-05
Accepted
2022-04-05 16:22:49
Documents
1
Period of Report
2022-04-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164919014507684.html 4  
1 FORM 4 wf-form4_164919014507684.xml 4 3591
  Complete submission text file 0001367644-22-000061.txt   4982
Mailing Address C/O UROVANT SCIENCES, INC. 5281 CALIFORNIA AVENUE, SUITE 100 IRVINE CA 92617
Business Address
Katkin Keith (Reporting) CIK: 0001314596 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33137 | Film No.: 22807179

Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations